September 13, 2007 - Millennium Research Group (MRG) conducted a detailed analysis of the stem cell therapy market in its "U.S. Markets for Stem Cell Therapies 2007" report, which shows while the market for stem cell therapies is in its infancy, it will grow rapidly as products are approved in the U.S.

September 12, 2007 - Texas Scottish Rite Hospital for Children (TSRHC) in Dallas has picked Siemens Medical Solutions to implement the MedSeries4 health information system (HIS), designed specifically to support rural and community healthcare providers.

September 12, 2007 - Westchester Medical Center has selected the Canopy care management solution from Allscripts to help manage and coordinate care for its patients.

September 12, 2007 – The 14th Annual Ambulatory Surgery Center Conference & Exhibits being held October 18-20 2007, at the Westin Michigan Avenue Hotel in Chicago, IL, will present topics that address improving profitability and the business and legal issues ASCs face today, organizers announced.

The conference is being co-hosted by ASC Communications, publisher of Becker's ASC Review, and FASA, the nation's largest trade association for ambulatory surgery centers.

Over 550 surgeons, ASC owners/operators, and top-level execs in the ASC sector, are expected to attend.

September 12, 2007 - Rochester Medical Corp. said a newly published clinical study demonstrates the effectiveness of the company’s proprietary infection control technology with nitrofurazone-impregnated urinary catheters.

September 12, 2007 - Researchers at the Stanford University School of Medicine have developed a molecular probe that sets aglow tumor cells within living animals. Their goal is to use the probe to improve the diagnosis and treatment of cancer and other diseases.

September 12, 2007 — BD Diagnostics announced that it has made a 510(k) submission to the FDA for additional claims for the BD GeneOhm StaphSR assay.

This will be the first assay for rapid and simultaneous identification of Staphylococcus aureus (SA) and methicillin-resistant Staphylococcus aureus (MRSA) from patients colonized in the nasal passage.

September 12, 2007 — Tangerine peel could help in the fight against certain cancers, researchers recently reported.
Human cancer cells, which contain an enzyme called P450 CYP1B1, were destroyed by a compound contained in tangerine peel, Salvestrol Q40, scientists at Leicester School of Pharmacy found.
The findings may offer a new approach to uncovering a treatment for cancers such as breast, lung, prostate and ovarian cancer, the scientists said.

September 12, 2007 – Innocoll Technologies Ltd. has entered into a strategic collaboration with TGR BioSciences Pty Ltd. to evaluate the combination of Innocoll's collagen-based drug delivery technology, CollaRx, with TGR Biosciences’ proprietary wound healing compound, TGR-265.

September 13, 2007 - Alphatec Holdings Inc., a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, entered into an exclusive worldwide license for a unique vertebroplasty technology system that is focused on providing a solution for vertebral compression fractures.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now